Tracking Stocks at Genzyme (A) Case Solution
Genzyme, a tracking stock leader, has used its advanced capital structure as a way to frame and grow its R&D-intensive company.
Confronting the question of how best to incorporate a brand new purchase into its tracking stock structure, Genzyme's top management is compelled to review how tracking stocks add worth to Genzyme, whether this value is sustainable, what future administration and control issues the current arrangement might present, and how these issues might be best managed. This is a rewritten version of an earlier note.
This is just an excerpt. This case is about FINANCE & ACCOUNTING
PUBLICATION DATE: November 14, 2001 PRODUCT #: 902023-PDF-ENG
Related Case Solutions & Analyses:
Offshoring at Global Information Systems Inc.
ETrade Securities Inc.
Restructuring in the 1990s (A)
Ernst & Young United Kingdom (A) (Abridged)
California Choppers
Regulation: A Transaction Cost Perspective
Williamson’s Contribution and Its Relevance to 21st Century Capitalism
Canadian Pacific’s Bid for Norfolk Southern
The Blackstone Group’s IPO, Chinese Version
Subprime Meltdown: American Housing and Global Financial Turmoil, Chinese Version
